Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents.

Sharp M, Donnelly SC, Moller DR

DOI: 10.1016/j.yrmex.2019.100004
Published: 2019
Container: Respiratory medicine: X
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.yrmex.2019.100004,
  title = {Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents.},
  author = {Sharp M and Donnelly SC and Moller DR},
  year = {2019},
  journal = {Respiratory medicine: X},
  doi = {10.1016/j.yrmex.2019.100004},
  url = {https://doi.org/10.1016/j.yrmex.2019.100004}
}

RIS

TY  - JOUR
TI  - Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents.
AU  - Sharp M
AU  - Donnelly SC
AU  - Moller DR
PY  - 2019
JO  - Respiratory medicine: X
DO  - 10.1016/j.yrmex.2019.100004
UR  - https://doi.org/10.1016/j.yrmex.2019.100004
ER  -

APA

M, S., SC, D., & DR, M. (2019). Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents.. Respiratory medicine: X. https://doi.org/10.1016/j.yrmex.2019.100004

Source records

pubmed · retrieved 2026-09-26T18:18:16.824Z